Abstract
Survival has improved among patients with diffuse large B-cell lymphoma (DLBCL) with the addition of anti-CD20 antibody therapy. We aimed to quantify trends and remaining loss in expectation of life (LEL) due to DLBCL at a national population-based level. Patients diagnosed with DLBCL 2000-2013 (N=7114) were identified through the Swedish Lymphoma Registry and classified according to the age-adjusted International Prognostic Index (aaIPI).The novel measure LEL is the difference between remaining life years among patients and the general population and was predicted using flexible parametric models from diagnosis and among 2-year survivors, by age and sex. Median age at DLBCL-diagnosis was 70 (range 18-105) years and 54.8% presented with stage III-IV disease. On average, LEL due to DLBCL decreased from 8.0 (95%CI 7.7-8.3) to 4.6 (95%CI 4.5-4.6) years over the study period. By risk group, LEL was most reduced among patients with aaIPI≥2 aged 50-60 years. However, these patients were still estimated to lose >8 years in 2013 (e.g., LELmales50years 8.6 years (95%CI 5.0-12.3)). Among 2-year survivors, LEL was reduced from 6.1 years (95%CI 5.6-6.5) (aaIPI≥2) and 3.8 years (95%CI 3.6-4.1) (aaIPI<2) to 1.1 (95%CI 1.1-1.2) and 1.0 year (...Continue Reading
References
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
May 2, 2006·The Lancet Oncology·Michael PfreundschuhUNKNOWN MabThera International Trial Group
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Sep 26, 2007·Statistics in Medicine·Christopher P NelsonDavid R Jones
Jun 9, 2009·European Journal of Epidemiology·Jonas F LudvigssonAnders Ekbom
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marita ZiepertMarkus Loeffler
Sep 17, 2013·Statistics in Medicine·Therese M-L AnderssonPaul C Lambert
Feb 20, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew J MaurerJames R Cerhan
May 9, 2015·Future Oncology·Pierre Feugier
May 20, 2015·BMC Cancer·Therese M-L AnderssonPaul C Lambert
Sep 16, 2015·Hematological Oncology·Tove WästerlidMats Jerkeman
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hannah BowerTherese M-L Andersson
Oct 30, 2016·British Journal of Haematology·Christopher M MelénBjörn Engelbrekt Wahlin
Nov 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hannah BowerTherese M-L Andersson
Jan 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lasse Hjort JakobsenTarec Christoffer El-Galaly
Citations
Nov 6, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J Maurer, T M Habermann
May 7, 2019·Leukemia & Lymphoma·Lasse Hjort JakobsenTarec Christoffer El-Galaly
May 26, 2020·Leukemia & Lymphoma·Anna AsklidLotta Hansson
Feb 18, 2020·British Journal of Haematology·Sara EkbergSandra Eloranta
Jun 19, 2019·American Journal of Hematology·Chava PerryIrit Avivi
Mar 15, 2020·Calcified Tissue International·Peter JohanssonCatharina Lewerin
Jul 14, 2020·Journal of Internal Medicine·S ElorantaT M Andersson
Sep 29, 2020·International Journal of Epidemiology·Luigino Dal MasoUNKNOWN EUROCARE-5 Working Group
May 14, 2020·British Journal of Haematology·Kristina SonneviBjörn E Wahlin
Nov 26, 2020·British Journal of Haematology·Tove WästerlidKarin E Smedby
Jan 13, 2021·Pharmacoepidemiology and Drug Safety·Lasse Hjort JakobsenTarec Christoffer El-Galaly
Dec 31, 2020·OncoTargets and Therapy·Haiping ZengZhiqiang Chen
May 6, 2021·British Journal of Haematology·Amal Abu SabaaGunilla Enblad
May 19, 2021·Journal of Internal Medicine·S EkbergS Eloranta
Jun 11, 2021·Journal of Internal Medicine·O Landgren